Carbovir
Alternative Names: NSC 614846Latest Information Update: 02 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antiretrovirals; Nucleosides; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 01 Mar 1999 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)
- 01 Sep 1998 Profile reviewed
- 20 Sep 1995 Preclinical development for HIV infections treatment in USA (Unknown route)